6th RNA-Targeted Drug Discovery and Development Summit

Improve Rational Design, Specificity and Selectivity of Direct and Indirect RNA Binders to Reduce Toxicity in Preclinical Models and Enable Robust Translation into the Clinic

Time: 8:15 AM – 4:15 PM

Venue Details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices:
Conference + Focus Day – Drug Developer Pricing: USD 4946.00,
Conference + Workshop Day – Drug Developer Pricing: USD 4946.00,
Conference Only – Drug Developer Pricing: USD 2999.00,
Conference + Focus Day – Academic Pricing: USD 4246.00,
Conference + Workshop Day – Academic Pricing: USD 4246.00,
Conference Only – Academic Pricing: USD 2599.00,
Conference + Focus Day – Vendor Pricing: USD 6046.00,
Conference + Workshop Day – Vendor Pricing: USD 6046.00,
Conference Only – Vendor Pricing: USD 3799.00

Speakers: Matt Disney, Professor and Chair of Chemistry, Scripps Research, Jennifer Petter, Founder and Chief Innovation Officer, Arrakis Therapeutics, Hashim Al-Hashimi, Co-Founder and Platform Architect, Base4 Biotechnology, Andrew Krueger, Research Investigator, Novartis, Peng Yue, Chief Executive Officer and Co-Founder, ReviR Therapeutics , and more